AP3B1 and Hermansky-Pudlak syndrome: Our decision to select HPS-2 mice was based on the understanding that mutations in Ap3b1 are linked to HPS pulmonary fibrosis in humans and enhance the sensitivity to bleomycin in mice [20, 26, 32].